title: [Rhabdomyolysis in cardiac transplant recipient due to verapamil interaction with simvastatin and cyclosporin treatment].
authors.forename: Anne
authors.initials: A
authors.lastname: Chiffoleau
authors.forename: Jean-Noël
authors.initials: JN
authors.lastname: Trochu
authors.forename: Gwenaëlle
authors.initials: G
authors.lastname: Veyrac
authors.forename: Thierry
authors.initials: T
authors.lastname: Petit
authors.forename: Patrick
authors.initials: P
authors.lastname: Abadie
authors.forename: Michel
authors.initials: M
authors.lastname: Bourin
authors.forename: Pascale
authors.initials: P
authors.lastname: Jolliet
mesh_terms: D002121:Calcium Channel Blockers / Q000009:adverse effects*; D016572:Cyclosporine / Q000009:adverse effects*; D004347:Drug Interactions; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000503:physiopathology; D019821:Simvastatin / Q000009:adverse effects*; D014700:Verapamil / Q000009:adverse effects*
chemical_list: D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D019821:Simvastatin; D014700:Verapamil